A subcutaneous (SC) injection version of Roche’s big-selling multiple sclerosis therapy Ocrevus has matched the current intravenous form in a clinical trial and, according to the company, could boost ...

Ocrevus, Roche’s first ever treatment for people with a highly debilitating type of multiple sclerosis is too expensive for the NHS in this form of the disease, NICE has ruled in a preliminary ...

Infusion therapy sends medication directly into the bloodstream to treat multiple sclerosis. Infusions can take four or more hours, and comfort items like blankets may be offered. Common ...